Guidance on applications for drug clinical trials under the interim order: Post-authorization requirements (French, HTML)

Guidance on applications for drug clinical trials under the interim order: Post-authorization requirements: French HTML file. From Health Canada, updated May 2021. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2021-05-28

Guidance document provides applicants seeking authorization to conduct COVID-19 drug clinical trials specifically around the applications guidelines and process.

Access original file

Data overview

Formats
HTML
File languages
French
Available actions
Access original file

Official sources and licences

Related open data